Please provide your email address to receive an email when new articles are posted on . Long-term CRT-D use was tied to improved survival and time to adverse events vs. ICD therapy in patients with ...

Receipt of a cardiac-resynchronization therapy-defibrillator (CRT-D) offers long term benefit for patients with heart failure, reduced ejection fraction, and a widened QRS complex, according to a ...

Please provide your email address to receive an email when new articles are posted on . A novel implantable cardioverter defibrillator platform may benefit patients with HF not eligible for cardiac ...

Pacemakers and defibrillators have a growing use in pediatrics and in patients with congenital heart disease, but they present unique problems and implications for their implantation and follow-up.

MINNEAPOLIS -- The novel dual-function cardiac contractility modulation-defibrillator (CCM-D) for heart failure with reduced ejection fraction (HFrEF) had favorable early results in the Integra-D ...

MINNEAPOLIS--(BUSINESS WIRE)--Cardialen, Inc., has published a first-in-human study in the Journal of the American College of Cardiology: Clinical Electrophysiology titled Novel Low-Voltage MultiPulse ...

BERLIN, Feb. 12, 2026 /PRNewswire/ -- BIOTRONIK today announced the launch of the new Acticor Sky and Rivacor Sky device family featuring the world's first CE-approved left bundle branch area pacing ...